Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE1/PHASE2
136 participants
INTERVENTIONAL
2012-04-30
2012-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Point-of-care Ultrasound Guidance for Distal Radius Fracture Reduction
NCT02962206
Ultrasound Directed Reduction of Colles Type Distal Radial Fractures in ED (UDiReCT)
NCT03868696
Bone Ultrasound to Access Fracture Healing
NCT02769117
Ultrasound Guided Hematoma Block in Distal Forearm Fractures
NCT05537831
Trial of Ultrasound Guidance for Reduction of Pediatric Forearm Fractures
NCT03097757
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Emergency ultrasound (EU) in Canada has become a well-established part of emergency medical practice in recent years as evidenced by the latest position statement of the Canadian Association of Emergency Physicians (http://caep.ca/template.asp?id=B5283F4158FB471AA56E480D6277C1AC) and the development of the Canadian Emergency Ultrasound Society (www.ceus.ca). A growing body of literature has shown the utility of EU in the diagnosis and reduction of fractures (1-6). A recent case report (7) showed that EU can be used to aid Colles fracture reduction. Similar to fluoroscopy, EU may be a fast and accurate method of determining successful fracture reduction. Unlike fluoroscopy, EU is available immediately in the ED. EU may also obviate the need for the post-reduction x-ray, particularly in the setting where the patient will have yet another x-ray at the time of orthopedic follow-up to evaluate for interval loss of reduction. Thus, EU has the potential to significantly reduce time to discharge.
Our study has the following objectives:
* To assess EU utility for guiding reduction attempts of distal radius fractures.
* To compare EU to x-ray for the final assessment of reduction adequacy.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ultrasound colles fracture
This is a single arm study
Point of care ultrasound
A bedside ultrasound machine will be used to image the colles fracture during the fracture reduction process.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Point of care ultrasound
A bedside ultrasound machine will be used to image the colles fracture during the fracture reduction process.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Able to provide voluntary and informed consent
* Distal radius fracture is the main traumatic injury
* Planned reduction to be performed by the EP
* Treating EP trained to perform EU for fractures OR one of the study authors available to perform EU
Exclusion Criteria
* Patient unable to provide voluntary and informed consent
* Distal radius fracture is only one of several significant injuries
* No reduction to be performed by the EP
* EP not trained to perform EU for fractures AND no study author available to perform EU
19 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of British Columbia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Andrew Skinner
Dr. William Andrew Skinner
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Andrew Skinner, MD
Role: PRINCIPAL_INVESTIGATOR
St. Paul's Hospital
Steve Socransky, MD
Role: STUDY_DIRECTOR
Sudbury Regional Hospital
Ray Wiss, MD
Role: STUDY_DIRECTOR
Sudbury Regional Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Foothills Medical Center
Calgary, Alberta, Canada
Namnaimo General Hospital
Nanaimo, British Columbia, Canada
St. Paul's Hospital
Vancouver, British Columbia, Canada
Saint John Regional Hospital
Saint John, New Brunswick, Canada
St. John's Health Science Center
St. John's, Newfoundland and Labrador, Canada
Dartmouth General Hospital
Dartmouth, Nova Scotia, Canada
Sudbury Regional Hospital
Greater Sudbury, Ontario, Canada
Toronto East General Hospital
Toronto, Ontario, Canada
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Andrew Skinner, MD
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Andrew Skinner, MD
Role: primary
Steve Socransky, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SPH-POCUS-2012
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.